We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
6.62 USD -0.38 ( 5.36%)
Last update at 2026-11-12T15:35:00Z
VOLUME
79151
Market Cap
442.32M
P/E
28.37

Momentum Score

…

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
6.60
Low
6.95
High
52 Week Price Range
4.78
Low
7.72
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
7.00
Dividend Yield
-
Revenue TTM
272.77M
Revenue Per Share
4.64
Gross Profit TTM
156.12M
Debt / Equity
0.26
ROE
5.22%
Net Debt
-67.71M
ROCE
1.50%
Diluted EPS TTM
0.27

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 7.00M 14.14M 6.63M -1.18M 13.74M
Minority interest 0.00M 0.03M 0.03M 0.03M 0.01M
Net income 7.41M 13.44M 6.72M -2.15M 13.15M
Selling general administrative 85.51M 39.60M 79.81M 35.14M 32.60M
Selling and marketing expenses 10.81M 61.62M 10.44M 62.12M 49.15M
Gross profit 146.91M 150.82M 142.16M 128.76M 117.28M
Reconciled depreciation 21.70M 21.76M 21.57M 22.57M 20.52M
Ebit 4.94M 9.43M 11.89M 3.24M 17.84M
Ebitda 25.79M 31.24M 33.02M 25.81M 38.35M
Depreciation and amortization 20.85M 21.81M 21.13M 22.57M 20.52M
Operating income 4.94M 9.43M 11.89M 3.24M 17.84M
Other operating expenses 252.13M 257.33M 238.98M 234.90M 193.23M
Interest expense 5.39M 1.65M 1.75M 4.42M 4.10M
Tax provision -0.43M 0.73M 0.08M 0.97M 0.59M
Interest income 2.84M 4.25M 3.48M 6.11M 5.62M
Net interest income 0.78M 2.60M 2.36M 1.69M 1.52M
Income tax expense -0.41M 0.73M 0.08M 0.97M 0.59M
Total revenue 257.07M 266.76M 250.88M 232.02M 205.45M
Total operating expenses 141.97M 141.39M 130.26M 131.64M 105.06M
Cost of revenue 110.16M 115.94M 108.72M 103.26M 88.17M
Total other income expense net 2.06M 4.71M -5.26M -4.42M -4.10M
Net income from continuing ops 7.72M 13.41M 6.69M -2.15M 13.14M
Net income applicable to common shares - - - -2.12M 13.15M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 420.47M 396.34M 396.96M 411.26M 413.41M
Intangible assets 25.63M 29.97M 31.46M 37.88M 31.67M
Other current assets 19.84M 18.16M 9.17M 8.42M 8.94M
Total liab 165.09M 147.84M 160.17M 182.33M 180.83M
Total stockholder equity 255.45M 248.58M 236.84M 228.96M 232.58M
Other current liab 17.90M 16.95M 17.49M 18.80M 16.75M
Common stock 4.49M 4.49M 4.49M 4.49M 4.47M
Capital stock 4.49M 4.49M 4.49M 4.49M 4.49M
Retained earnings 47.16M 19.00M -1.78M -9.43M -0.91M
Other liab - - - 15.20M 11.49M
Good will 43.14M 43.39M 43.19M 44.16M 18.73M
Other assets - - - 0.00M 7.75M
Cash 133.86M 102.30M 127.68M 140.87M 196.03M
Total current liabilities 91.84M 102.18M 105.04M 106.11M 91.43M
Current deferred revenue 43.50M 46.00M 40.82M 41.72M 33.31M
Net debt -67.71M -61.02M -63.23M -59.89M -96.92M
Short term debt 10.32M 13.00M 25.50M 19.96M 21.20M
Short long term debt 7.76M 10.38M 22.87M 17.06M 17.85M
Short long term debt total 66.15M 41.28M 64.45M 80.98M 99.11M
Other stockholder equity 203.81M 234.23M 238.63M 242.16M 235.77M
Property plant equipment - - - 102.70M 93.50M
Total current assets 223.51M 190.51M 206.64M 216.41M 257.80M
Long term investments 0.00M 3.99M 3.74M 3.80M 3.96M
Net tangible assets - - - 146.93M 182.18M
Net receivables 54.91M 53.05M 52.74M 51.04M 41.54M
Long term debt 49.73M 23.18M 33.58M 55.87M 72.64M
Inventory 14.90M 16.99M 17.05M 16.08M 11.29M
Accounts payable 20.12M 23.35M 21.21M 25.63M 20.17M
Accumulated other comprehensive income - -9.08M -7.35M -8.27M -6.75M
Non currrent assets other 5.98M 9.41M 5.57M 5.13M 7.52M
Non current assets total 196.96M 205.82M 190.32M 194.85M 155.60M
Capital lease obligations 5.63M 7.73M 7.94M 8.05M 8.62M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -28.59M -14.00M -53.92M -13.13M
Change to liabilities - - - 22.62M 6.45M
Total cashflows from investing activities -9.32M -28.59M - -53.86M -13.13M
Net borrowings 20.88M -26.39M - -21.09M -18.05M
Total cash from financing activities 18.00M -27.64M -20.20M -24.87M 71.16M
Net income 7.41M 13.41M 6.58M -2.15M 13.14M
Change in cash 43.70M -25.27M -12.79M -55.16M 84.49M
Begin period cash flow 90.16M 127.57M 140.47M 196.03M 111.54M
End period cash flow 133.86M 102.30M 127.68M 140.87M 196.03M
Total cash from operating activities 22.68M 31.46M 18.03M 24.71M 25.84M
Issuance of capital stock - 0.00M 0.02M 0.02M 88.12M
Depreciation 20.85M 21.76M 21.13M 22.57M 20.52M
Other cashflows from investing activities 5.93M -1.27M - - 0.00M
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory -0.87M -0.37M -0.79M -5.01M -1.42M
Change to account receivables -2.57M -1.04M -3.27M -6.33M -10.92M
Other cashflows from financing activities -5.01M -1.25M -0.34M -1.47M -2.42M
Change to netincome - - - 0.82M -1.94M
Capital expenditures 13.54M 26.38M 11.52M 24.77M 11.72M
Change in working capital -8.49M -1.42M -12.32M 3.44M -5.89M
Stock based compensation 0.27M 0.28M 0.04M -0.14M -1.04M
Other non cash items 3.34M -2.58M 2.53M 0.03M -1.48M
Free cash flow 9.14M 5.08M 6.51M -0.06M 14.12M

Peer Comparison*

Sector: Technology Industry: Software - Application

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MTLS
Materialise NV
-0.38
5.36%
6.62 28.37 625.00 1.62 1.48 1.13 7.97
SAP
SAP SE ADR
-0.29
0.12%
233.81 28.16 22.42 6.52 4.85 5.60 16.61
CRM
Salesforce Inc
-2.48
1.14%
215.53 23.41 15.55 4.79 5.56 5.55 14.88
SAPGF
SAP SE
0.50
0.21%
234.50 76.28 22.88 5.61 3.84 5.59 26.18
SHOP
Shopify Inc
-1.14
0.76%
148.12 90.18 53.19 12.70 13.17 12.23 67.86

Profile*

Materialise NV

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Technologielaan 15, Leuven, Belgium, 3001

32 1 639 66 11

2556

Name Title Year Born
Mr. Johan Pauwels Exec. VP & COO 1968
Mr. Peter E. Leys Exec. Chairman 1965
Mr. Wilfried Vancraen Founder, CEO & Director 1962
Mr. Johan Albrecht Exec. VP & CFO 1963
Mr. Bart Van der Schueren Exec. VP & CTO 1968
Ms. Carla Van Steenbergen VP, Chief Legal Officer, Compliance Officer & Sec. 1976
Ms. Conny Hooghe VP of HR 1966
Ms. Hilde Ingelaere Exec. VP of Medical & Director 1963
Mr. Filip Dehing Chief Exec. Officer of RapidFit NV 1971
Ms. Brigitte de Vet-Veithen Chief Executive Officer 1972

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…